Sowbhagya Suresh
컨설턴트
Expertise:
Sowbhagya is an Associate Consultant at EVERSANA APAC. She has more than 2 years of experience in healthcare. She has worked with several MNC clients on market entry assessments, valuation of assets in rare indications, deal negotiation strategies and opportunity assessment engagements across G7 and APAC countries.
EVERSANA 입사 전에는 Decision Resources Group과 바이오테크 스타트업인 MetFlux Research에서 일했습니다. 인도 카르나타카 소재 국립공과대학교(NIT)에서 학사 학위를 받았으며 화학공학을 전공했습니다."
Articles by Sowbhagya Suresh
Learning How to Play Dilution Dodgeball
The healthcare industry is reaching new heights in innovation, and as new drugs are founded, owners of biotech companies must decide whether or not they want to independently bring their product to market. Developing and successfully commercializing a biopharma product is no small undertaking. The multi-year journey is fraught with clinical, financial and operational uncertainties that many companies fail […]
Escaping the Chronic Microcap Trap: How Launching Alone Is the Only Option for Growth
As C-suite leaders in pharma wrestle with the pros and cons of launching alone, licensing or partnering with another company to launch their product, one factor they must consider is the impact their decision will have on their current and future market valuation. The question is this: How much of a premium does the market […]
The Chronic Microcap Trap: How Launch Is The Escape for True Growth
Pre-commercial pharma companies face a common choice: commercialize products independently or collaborate with another pharmaceutical company as a commercialization partner. As the C-suite leaders in these organizations wrestle with the pros and cons of this choice, one factor they must consider is the impact their decision will have on their current and future market valuation. […]